Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Find beginner-friendly options with understandable use cases and liquidity, plus a simple framework to compare potential investments.
27,615 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Oil trades around $80 a barrel on June 17, 2026, with Brent at $80.78. The piece breaks down what this means for cons...
Adobe stock is staging a comeback after a brutal selloff, with stronger earnings and AI-driven growth fueling optimis...
An in-depth look at how much SCHD would be required to replace Social Security income, with current yields, market co...
Citigroup boosts its SanDisk price target to $2,500, arguing a multi-year datacenter expansion and a tighter NAND cyc...
A rising governance proposal centers on a 5% government stake in OpenAI, aiming to align AI safety with policy goals ...
Apple extends Broadcom’s supply agreement through 2031, anchoring cash flow and accelerating AI chip growth. Here’s w...
Apple unveils a multiyear AI silicon plan, signaling a major shift toward in-house AI hardware. Our analysis maps a p...
Chipotle launches its first Monterrey location with Alsea, kicking off a broader push into Mexico. The move tests wal...
Meta Platforms is delivering stronger fundamentals even as the stock trades at a cautious multiple. This article argu...
Japan’s first female prime signals a bold pivot toward U.S. cooperation on rare earths and economic security, a move ...
The Florida Chamber argues that high-tax policies in other states are pushing capital and residents toward Florida, r...